Armadillo Repeat-Containing Protein 8 (ARMC8) Silencing Inhibits Proliferation and Invasion in Osteosarcoma Cells

被引:12
作者
Jiang, Feng [1 ]
Shi, Yan [2 ]
Lu, Hong [2 ]
Li, Guojun [1 ]
机构
[1] Henan Univ, Huaihe Hosp, Dept Orthoped, Kaifeng, Henan Province, Peoples R China
[2] Henan Univ, Huaihe Hosp, Dept Oncol, 8 Baobei Rd, Kaifeng 475000, Henan Province, Peoples R China
关键词
Armadillo repeat-containing protein 8 (ARMC8); Osteosarcoma; Proliferation; Invasion; CATENIN PATHWAY; CANCER CELLS; ARMC8-ALPHA; INVASIVENESS; EXPRESSION; COMPLEX; EMT;
D O I
10.3727/096504016X14685034103392
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Armadillo repeat-containing protein 8 (ARMC8) plays an important role in regulating cell migration, proliferation, tissue maintenance, signal transduction, and tumorigenesis. However, the expression pattern and role of ARMC8 in osteosarcoma are still unclear. In this study, our aims were to examine the effects of ARMC8 on osteosarcoma and to explore its underlying mechanism. Our results demonstrated that ARMC8 was overexpressed in osteosarcoma cell lines. Knockdown of ARMC8 significantly inhibited osteosarcoma cell proliferation in vitro and markedly inhibited xenograft tumor growth in vivo. ARMC8 silencing also suppressed the epithelial-mesenchymal transition (EMT) phenotype, as well as inhibited the migration and invasion of osteosarcoma cells. Furthermore, knockdown of ARMC8 obviously inhibited the expression of beta-catenin, c-Myc, and cyclin Dl in MG-63 cells. In conclusion, this report demonstrates that ARMC8 silencing inhibits proliferation and invasion of osteosarcoma cells. Therefore, ARMC8 may play an important role in the development and progression of human osteosarcoma and may represent a novel therapeutic target in the treatment of osteosarcoma.
引用
收藏
页码:381 / 389
页数:9
相关论文
共 22 条
[1]   Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma [J].
Cai, Yongping ;
Mohseny, Alexander B. ;
Karperien, Marcel ;
Hogendoorn, Pancras C. W. ;
Zhou, Gengyin ;
Cleton-Jansen, Anne-Marie .
JOURNAL OF PATHOLOGY, 2010, 220 (01) :24-33
[2]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[3]  
Edward ED, 2015, PAEDIATR INDONES, V55, P121
[4]   Armc8 expression was elevated during atypia-to-carcinoma progression and associated with cancer development of breast carcinoma [J].
Fan, Chuifeng ;
Zhao, Yang ;
Mao, Xiaoyun ;
Miao, Yuan ;
Lin, Xuyong ;
Jiang, Guiyang ;
Zhang, Xiupeng ;
Han, Qiang ;
Luan, Lan ;
Wang, Enhua .
TUMOR BIOLOGY, 2014, 35 (11) :11337-11343
[5]  
Fiori R., 2015, INT J CASE REP IMAGE, V6, P224
[6]   Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor [J].
Geller, David S. ;
Revskaya, Ekaterina ;
Khan, Mani ;
Morris, Jonathan ;
Gorlick, Richard ;
Dadachova, Ekaterina .
CANCER RESEARCH, 2015, 75
[7]   Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-β-catenin pathway [J].
Hoang, BH ;
Kubo, T ;
Healey, JH ;
Yang, R ;
Nathan, SS ;
Kolb, EA ;
Mazza, B ;
Meyers, PA ;
Gorlick, R .
CANCER RESEARCH, 2004, 64 (08) :2734-2739
[8]   ARMc8 indicates aggressive colon cancers and promotes invasiveness and migration of colon cancer cells [J].
Jiang, Guiyang ;
Zhang, Yong ;
Zhang, Xiupeng ;
Fan, Chuifeng ;
Wang, Liang ;
Xu, Hongtao ;
Yu, Juanhan ;
Wang, Enhua .
TUMOR BIOLOGY, 2015, 36 (11) :9005-9013
[9]   Epithelial-Mesenchymal Transition in tumor microenvironment [J].
Jing, Yingying ;
Han, Zhipeng ;
Zhang, Shanshan ;
Liu, Yan ;
Wei, Lixin .
CELL AND BIOSCIENCE, 2011, 1
[10]  
Kaya M., 2016, OSTEOSARCOMA, P73